EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia

T. Kyriakides, C. Angelini, J. Schaefer, S. Sacconi, G. Siciliano, J. J. Vilchez, D. Hilton-Jones

Research output: Contribution to journalReview article

95 Citations (Scopus)

Abstract

Objective: To provide evidence-based guidelines to general neurologists for the assessment of patients with pauci- or asymptomatic hyperCKemia. Background: Recent epidemiologic studies show that up to 20% of 'normal' individuals have an elevated creatine kinase activity in the serum (sCK). The possibility of a subclinical myopathy is often raised, and patients may be unnecessarily denied treatment with statins. Search strategy: Electronic databases including Medline, the Cochrane Library and the American Academy of Neurology were searched for existing guidelines. Articles dealing with series of patients investigated for asymptomatic/pauci-symptomatic hyperCKemia and articles dealing with myopathies that can present with asymptomatic hyperCKemia were identified and reviewed. Results: The only guidelines found were those approved by the Italian Association of Myology Committee, and the only relevant articles identified describe class IV studies. Recommendations: HyperCKemia needs to be redefined as values beyond 1.5 times the upper limit of normal (which itself needs to be appropriately defined). Pauci- or asymptomatic hyperCKemia with no apparent medical explanation may be investigated with a muscle biopsy if one or more of the following are present; the sCK is ≥3× normal, the electromyogram is myopathic or the patient is <25 years of age. In addition, women with sCK<3 times normal may be offered DNA testing because of the possibility of carrying a dystrophin mutation.

Original languageEnglish
Pages (from-to)767-773
Number of pages7
JournalEuropean Journal of Neurology
Volume17
Issue number6
DOIs
Publication statusPublished - 2010

Keywords

  • Asymptomatic
  • HyperC-Kemia
  • Investigation
  • Pauci-symptomatic

Fingerprint Dive into the research topics of 'EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia'. Together they form a unique fingerprint.

  • Cite this

    Kyriakides, T., Angelini, C., Schaefer, J., Sacconi, S., Siciliano, G., Vilchez, J. J., & Hilton-Jones, D. (2010). EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. European Journal of Neurology, 17(6), 767-773. https://doi.org/10.1111/j.1468-1331.2010.03012.x